To analyse the effects of apnoea and bradycardia on the oxygen saturation (SaO2) of preterm infants and to make recommendations for apnoea alarm limits, polygraphic recordings were made on 89 occasions of 27 preterm infants; 1029 apnoeic episodes were analysed.
Apnoea of prematurity is one of the commonest problems encountered when caring for very low birthweight babies, and is likely to become more common as survival of such infants improves.' It is also associated with long term morbidity.2 Despite this, we have little knowledge of the acute effects of apnoeic attacks on the oxygenation of small preterm infants. Previous studies have used transcutaneous oxygen monitors to measure these effects, but they have slow response times in comparison with the average duration of an apnoeic episode. 5 Pulse oximetry has been shown to be extremely accurate in a neonatal population and overcomes the problem of slow response. 6 This study was therefore designed to examie the effects of apnoeic attacks on the oxygen saturation (SaO2) of preterm infants, as measured by pulse oximetry, and see how this relationship is affected by the presence of bradycardia and treatment with methylxanthines. With this information we hoped to make recommendations for the setting of alarm limits for apnoea detection that would avoid hypoxaemia and so-we hoped-limit later morbidity.
Subjects and methods Babies born at 32 weeks' gestation or less were studied. The infants were clinically stable, breathing air at the time of study and were not preselected for the presence of apnoea. Eighty nine studies were performed on 27 infants, many of whom were studied longtitudinally. Median birth weight of the infants was 1140 g (range 710-1700) and gestational age 29 weeks (range 25-32). Median day of study was 15 (range 1-55) and postconceptional age 32 weeks (range 26-36). There were 16 criteria were analysed. Of these, 605 were accompanied by bradycardia of which 83 seemed to occur without apnoea. Most of the bradycardias (522, 86% of the total) were therefore associated with apnoea. In 424 episodes apnoea occurred without bradycardia.
There was a positive correlation between the reduction in SaO2 and the duration of apnoea (r=0-41, p<0 0001) (fig 1) . From the regression line one might expect that for an episode of apnoea lasting 10 seconds the reduction in SaO2 would be 90/o, and for an episode lasting 20 seconds a reduction of 13% would be likely. This does, however, hide an enormous variation in the results, and reductions in SaO2 of up to 400/o occurred with episodes of apnoea lasting less than 10 seconds.
The initial SaO2 value before the onset of an episode of apnoea also had an effect on the -reduction in SaO2, though it was weak (r=0-18, p<00001) ( fig 2) . Infants with poor baseline values of oxygenation, therefore, had greater reductions during apnoeic attacks than those who were well oxygenated. Such a relationship could have been predicted from the haemoglobin dissocation curve. Although the relationship was not strong, it remained significant in a stepwise multiple regression analysis when allowance was made for duration of apnoea, the presence of bradycardia, the frequency of apnoeic attacks, and treatment with theophylline. This was necessary because those episodes associated with bradycardia cover the whole rangec of duration of apnoeic attacks, whereas those ,,I _es without associated bradycardia had to be at least 10 seconds long to qualify. They became 100 increasingly less common as the apnoea attacks lengthened beyond 20 seconds, as bradycardia was then more likely to occur. There was a highly significant difference in reduction in (fig 1) , the spread is so great that no sensible alarm limit could totally prevent this degree of hypoxaemia. A much shorter alarm limit would, however, result in an unacceptably high number of alarms during apnoeic attacks not associated with falling SaO2.
Similarly, it is difficult to extrapolate a sensible apnoea alarm limit from the degree of bradycardia that is produced. This is because the correlation between minimum heart rate during episodes of bradycardia and apnoea is extremely poor (r=0 11, p<0 0001) (fig 3) . Bradycardia of less than 80 may occur with virtually any duration of apnoea, and therefore the minimum heart rate is not helpful in setting apnoea alarm limits. In practice this problem is overcome by routine electrocardiographic monitoring of infants at risk of apnoea. Discussion A poor degree of correlation between the duration of apnoea and the degree of oxygenation has been described by Peabody et al in a study in which they used transcutaneous oxygen monitoring.3 There are other important factors that determine the fall in oxygen tension during episodes of apnoea, which they discussed; these include oxygen consumption, metabolic rate, and functional residual capacity. They blamed Figure 3 Minimal heart rate during episodes ofbradycardia (beats/min) plotted against duration ofapnoea (s). Minimal heart rate=74-220-14xduration ofapnoea (r=O 1, p<0-0001). 383 these other confounding variables for producing the poor correlation but, in addition, the slow response time of transcutaneous monitors must have added to the variability in their results. Indeed, Muttitt et al have more recently shown a closer correlation using pulse oximetry.9 Their study, however, assumed that short episodes of apnoea were not harmful and only analysed those that lasted 15 seconds or longer. Our results have shown that this is a false assumption and that episodes lasting less than 10 seconds can result in reductions of SaO2 ofup to 400/o. As a result of including shorter episodes of apnoea in our study, we have shown an even greater degree of correlation between reduction in SaO2 and duration of apnoea.
Another important difference between our study and that of Muttitt et al is that they also monitored nasal airflow, whereas we only assessed external indicators of respiratory effort in detecting apnoea. This is important as in a clinical setting it is the apnoea alarms on these devices that we need to set, and relate to the oxygenation of the infant. Our study shows that the wide scatter of results makes this an almost impossible task, and that trying to relate duration of apnoea to heart rate is even more futile. Routine monitoring of nasal airflow is only done in a few neonatal units and it is interesting to note that when our study is compared with that of Muttitt et al, the use ofairflow did not help to predict reductions in SaO2 from duration of apnoea.
These data suggest that attempts to detect apnoea from external movements are not likely to be effective in preventing hypoxaemia in such infants. We would therefore suggest that a fundamental change is made in the way that we monitor infants at risk for apnoea. The poor correlation between heart rate and apnoea has meant that heart rate monitoring in apnoeic infants has become routine practice. Similarly we suggest that it is more appropriate to measure oxygen saturation in infants at risk to assess the degree of hypoxaemia being produced by the apnoea. The combination of electrocardiographic and SaO2 monitoring would allow the detection of potentially damaging episodes no matter how short or long, rather than of all episodes of apnoea, many of which may be harmless.
It has been hypothesised that apnoea of prematurity may be caused by central depression of the respiratory centre as a result of hypoxia."
The study of Hiatt et al has been used to show that such a mechanism is unlikely, as hypoxia was not noted to precede 72 apnoeic attacks. 4 Our study has shown, however, that the baseline SaO2 measurement is extremely variable and that hypoxia does precede a proportion of our 1029 episodes. Clearly, though, the role of hypoxia in the pathophysiology of apnoea cannot be further elucidated from a study such as ours. It is interesting to note, however, the importance of low baseline SaO2 measurements in the aetiology of bradycardia during an apnoeic attack. Our observation that bradycardia is more likely to occur when an infant is relatively hypoxaemic is supported by the study by Wennergren et al who showed in older infants that laryngeal chemoreflex bradycardia is potentiated in conditions of relative hypoxia. '2 As episodes of apnoea that result in bradycardia start with a relatively low SaO2, one would also expect a greater reduction in SaO2 during an episode of bradycardia compared with an episode of apnoea not accompanied by bradycardia. We have shown this, but using a six seconds averaging time on our oximeter we were unable to study the temporal relationship between a fall in SaO2 and the onset of bradycardia as described by Henderson-Smart et al. 3 They postulated that bradycardia was a peripheral chemoreflex response to falling SaO2. We feel, however, that one should be wary of ascribing cause and effect to this relationship, as bradycardia is more common when there is an obstructive element to the apnoea,'4 and episodes of apnoea with such an element may also be associated with a more pronounced reduction in SaO2. '5 It seems, therefore, that a mild degree of hypoxaemia predisposes to both bradycardia and larger reductions in SaO2. The implication of this is that it is important to keep infants with recurrent apnoeic attacks relatively well oxygenated. A delicate balance must be reached, however, to avoid hyperoxaemia, in view of the risks of development of retinopathy of prematurity. Unfortunately pulse oximeters are not reliable at excluding hyperoxaemia. The plateau at the top of the haemoglobin dissociation curve means that small increases in SaO2 above 90% may be associated with large increases in arterial oxygen tension. Consequently an upper alarm limit of 95% on the pulse oximeter is unreliable at excluding hyperoxaemia. 6 It seems that 92% is a more realistic upper alarm limit for the Ohmeda Biox 3700 pulse oximeter.6 Monitors vary considerably, however, and the optimal alarm limits'6 and accuracy'7 of different instruments also show wide variation. In addition, factors in the baby, in particular the amount of fetal haemoglobin, will affect the association between oxygen saturation and tension. We think therefore that in a baby with recurrent apnoea arterial blood gases should be checked to confirm hypoxaemia before the ambient oxygen concentration is increased. This may then be correlated with SaO2 and appropriate alarm limits for the individual infant calculated.
In practice, using an Ohmeda Biox 3700 monitor, we suggest an upper alarm limit for SaO2 of 92% and a lower limit of 82% as a reasonable guideline for infants nursed in oxygen. For 
